pharma · Recurrent Respiratory Tract Infections · Actinic Keratosis on the Face or Scalp
ALMIRALL S.P.A
Almirall, S.A.
ALMIRALL S.P.A is a pharma organization headquartered in Barcelona, IT. Primary therapeutic focus areas include Recurrent Respiratory Tract Infections, Actinic Keratosis on the Face or Scalp, Alopecia areata, Actinic Ker
VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona HQ
2 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona
- Employees
- 2
- Programs
- 11
- Drugs
- 20
- Patents
- 308
Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel
Approved · small molecule · Actinic Keratosis
Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel for Actinic Keratosis is a Approved program (small_molecule) at Almirall, S.A. with 1 ClinicalTrials.gov record(s).
Internal code M-14789-41
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Almirall, S.A.
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Actinic Keratosis
- Status
- active
- Trials
- 1